Cooperative Groups Advised To Plan For Future Of Less Funding from NCI
In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow
ODAC Recommends Ethyol, DaunoXome For FDA Approval
ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation
Cancer Panel Urges Improved Funding For Basic Science
FDA, NIH Streamline Approvals For Gene Therapy Studies
Report Criticizes NIH Grant Review
NIH Policy On Diversity In Sponsored Meetings
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
